WEDNESDAY, Oct. 11, 2023 (HealthDay News) — A medication already approved for excessive daytime sleepiness may help ease attention-deficit/hyperactivity disorder (ADHD) symptoms in adults who aren’t getting relief from available treatments, according to a small pilot study. Solriamfetol is a nonstimulant drug that is approved for sleepiness caused by narcolepsyContinue Reading

FRIDAY, Oct. 6, 2023 (HealthDay News) — As many as 1 in 4 teens with autism may be undiagnosed, new research suggests. “Autism is much more prevalent than people assume,” said lead researcher Walter Zahorodny, an associate professor at Rutgers New Jersey Medical School in Newark. The new study isContinue Reading